Apogem Capital’s Archrock AROC Stock Holding History

Apogem Capital’s Portfolio AROC Stock Details AROC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-41,437	Closed	-$342K	–	177
2021 Q3	$342K	Buy	+41,437	New	+$333K	0.22%	140

Other funds holding AROC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return

Apogem Capital's AROC Position: Q4 2021 in Review

Apogem Capital sold out of Archrock (AROC) in Q4 2021, closing a stake of 41,437 shares — an estimated $342K sold.

Apogem Capital first reported a position in AROC in Q3 2021 and held it in 1 quarter. The position peaked at $342K in Q3 2021. 210 funds tracked by Wall St. Rank hold AROC as of Q4 2021.

Apogem Capital reported no remaining Archrock position as of Q4 2021 after selling out during the quarter.
Apogem Capital sold 41,437 Archrock shares in Q4 2021, an estimated $342K.
Apogem Capital first reported a position in Archrock in Q3 2021 and held it in 1 quarter.
Apogem Capital's Archrock position peaked at $342K in Q3 2021.
210 funds tracked by Wall St. Rank held Archrock as of Q4 2021.

Based on Apogem Capital's 13F filing for Q4 2021, filed 14 Feb 2022.